Transforming growth factor-β induces apoptosis in antigen-specific CD4+ T cells prepared for adoptive immunotherapy
- 3 March 2003
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 86 (1) , 37-43
- https://doi.org/10.1016/s0165-2478(02)00307-3
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cellsNature Medicine, 2001
- Progress in human tumour immunology and immunotherapyNature, 2001
- Role of transforming growth factor beta in cancerJournal of Cellular Physiology, 2001
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Immunological ignorance of silent antigens as an explanation of tumor evasionImmunology Today, 1998
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Reversal of Tumor-Induced Immunosuppression: A New Approach to Cancer TherapyJournal of Immunotherapy, 1997
- Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.Proceedings of the National Academy of Sciences, 1996
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.Proceedings of the National Academy of Sciences, 1990